Exco Technologies Limited (FRA:3XT)

Intra-Cellular Therapies Statistics

Total Valuation

FRA:3XT has a market cap or net worth of EUR 159.56 million. The enterprise value is 208.91 million.

Market Cap	159.56M
Enterprise Value	208.91M

Important Dates

The last earnings date was Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	Jun 16, 2025

Share Statistics

Current Share Class	38.23M
Shares Outstanding	n/a
Shares Change (YoY)	-0.85%
Shares Change (QoQ)	-0.30%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	17.46M

Valuation Ratios

The trailing PE ratio is 10.74 and the forward PE ratio is 6.67.

PE Ratio	10.74
Forward PE	6.67
PS Ratio	0.41
PB Ratio	0.64
P/TBV Ratio	0.94
P/FCF Ratio	6.09
P/OCF Ratio	3.49
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.57, with an EV/FCF ratio of 7.97.

EV / Earnings	14.06
EV / Sales	0.54
EV / EBITDA	4.57
EV / EBIT	8.28
EV / FCF	7.97

Financial Position

The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.26.

Current Ratio	2.86
Quick Ratio	1.64
Debt / Equity	0.26
Debt / EBITDA	1.39
Debt / FCF	2.43
Interest Coverage	7.07

Financial Efficiency

Return on equity (ROE) is 6.13% and return on invested capital (ROIC) is 5.06%.

Return on Equity (ROE)	6.13%
Return on Assets (ROA)	4.15%
Return on Invested Capital (ROIC)	5.06%
Return on Capital Employed (ROCE)	7.77%
Revenue Per Employee	77,419
Profits Per Employee	2,972
Employee Count	5,000
Asset Turnover	1.02
Inventory Turnover	4.78

Taxes

In the past 12 months, FRA:3XT has paid 4.79 million in taxes.

Income Tax	4.79M
Effective Tax Rate	24.39%

Stock Price Statistics

The stock price has decreased by -17.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.67%
50-Day Moving Average	4.20
200-Day Moving Average	4.49
Relative Strength Index (RSI)	48.49
Average Volume (20 Days)	22

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:3XT had revenue of EUR 387.09 million and earned 14.86 million in profits. Earnings per share was 0.39.

Revenue	387.09M
Gross Profit	79.86M
Operating Income	25.11M
Pretax Income	19.65M
Net Income	14.86M
EBITDA	44.87M
EBIT	25.11M
Earnings Per Share (EPS)	0.39

Balance Sheet

The company has 14.68 million in cash and 63.77 million in debt, giving a net cash position of -49.09 million.

Cash & Cash Equivalents	14.68M
Total Debt	63.77M
Net Cash	-49.09M
Net Cash Per Share	n/a
Equity (Book Value)	247.40M
Book Value Per Share	6.47
Working Capital	100.94M

Cash Flow

In the last 12 months, operating cash flow was 45.71 million and capital expenditures -19.50 million, giving a free cash flow of 26.21 million.

Operating Cash Flow	45.71M
Capital Expenditures	-19.50M
Free Cash Flow	26.21M
FCF Per Share	n/a

Margins

Gross margin is 20.63%, with operating and profit margins of 6.49% and 3.84%.

Gross Margin	20.63%
Operating Margin	6.49%
Pretax Margin	5.08%
Profit Margin	3.84%
EBITDA Margin	11.59%
EBIT Margin	6.49%
FCF Margin	6.77%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 6.47%.

Dividend Per Share	0.27
Dividend Yield	6.47%
Dividend Growth (YoY)	-4.17%
Years of Dividend Growth	n/a
Payout Ratio	67.81%
Buyback Yield	0.85%
Shareholder Yield	7.31%
Earnings Yield	9.31%
FCF Yield	16.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6